Back to Search
PATRICK L PINE MD
MD
Family Medicine Physician
NPI: 1922184712IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
44789(AZ)MD22906(ME)
Education
OTHER
Class of 2006
Research & Publications (20)
Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen.
PMID 19609559·J Cancer Res Clin Oncol·2010
7-preclinical
JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL/J mice.
PMID 19596999·J Immunol·2009
7-preclinical
Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target.
PMID 18981293·Blood·2009
7-preclinical
Comparison of the diagnostic performance of human whole genome microarrays using mixed-tissue RNA reference samples.
PMID 18822358·Toxicol Lett·2009
4-observational
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
PMID 18438845·Arthritis Rheum·2008
7-preclinical
Assessment of repeated microarray experiments using mixed tissue RNA reference samples.
PMID 18778252·Biotechniques·2008
7-preclinical
Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.
PMID 19018007·J Immunol·2008
4-observational
Use of diagnostic accuracy as a metric for evaluating laboratory proficiency with microarray assays using mixed-tissue RNA reference samples.
PMID 19018728·Pharmacogenomics·2008
7-preclinical
Characterization of the effect of sample quality on high density oligonucleotide microarray data using progressively degraded rat liver RNA.
PMID 17854504·BMC Biotechnol·2007
7-preclinical
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor.
PMID 17537677·Clin Immunol·2007
7-preclinical
Using RNA sample titrations to assess microarray platform performance and normalization techniques.
PMID 16964226·Nat Biotechnol·2006
8-other
Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.
PMID 16192454·Am J Respir Crit Care Med·2006
7-preclinical
Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation.
PMID 16339999·Am J Respir Cell Mol Biol·2006
7-preclinical
A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes.
PMID 16452391·J Pharmacol Exp Ther·2006
8-other
Workgroup report: Review of genomics data based on experience with mock submissions--view of the CDER Pharmacology Toxicology Nonclinical Pharmacogenomics Subcommittee.
PMID 16581548·Environ Health Perspect·2006
6-review
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
PMID 16946104·J Pharmacol Exp Ther·2006
2-rct
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.
PMID 16964229·Nat Biotechnol·2006
4-observational
Improvement in the reproducibility and accuracy of DNA microarray quantification by optimizing hybridization conditions.
PMID 17118138·BMC Bioinformatics·2006
7-preclinical
Radical reactions of a stable N-heterocyclic germylene: EPR study and DFT calculation.
PMID 15941234·J Am Chem Soc·2005
8-other
Use of a mixed tissue RNA design for performance assessments on multiple microarray formats.
PMID 16377776·Nucleic Acids Res·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2080 W SOUTHERN AVE BLDG B10
APACHE JUNCTION, AZ 85120 - Phone
- (480) 351-2850
Quick Facts
- NPI
- 1922184712
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile